Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group studyBożena Katarzyna Budziszewska, Ewa Lech‐Marańda, Anna Ejduk et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 13
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra-Tybor, Krzysztof Jamroziak, Aleksandra Gołoś et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 2
Treatment of Elderly Patients with Acute Myeloid Leukemia Adjusted to Age, Performance Status, Organ Function and the Presence of Co-Morbidities. Final Results of the Polish Adult Leukemia Group (PALG) 1/2005 Study.Bożena Katarzyna Budziszewska, Agnieszka Wierzbowska, Agnieszka Pluta et al.|Blood|2010Cited by 1
Analysis of Predictive Factors for Early Response to Ruxolitinib in 266 Patients with Myelofibrosis from the Polish Adult Leukemia Group (PALG) RegistryJoanna Góra‐Tybor, Krzysztof Jamroziak, Aleksandra Gołoś et al.|Blood|2019Cited by 0